跳至主要内容
临床试验/RBR-10k4gqdg
RBR-10k4gqdg招募中未知

Vitamin D Supplementation in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Randomized, Double-Blind, Placebo-Controlled Clinical Trial

niversidade Estadual Paulista - Unesp0 个研究点开始时间: 2022年7月4日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
45Y 至 80Y(—)
性别
Female

入选标准

  • Women aged above 45 years with a recent histological diagnosis of breast cancer, eligible for neoadjuvant chemotherapy (presence of luminal tumors A or B with clinically positive armpit; luminal tumor B larger than three centimeters; triple negative tumor; tumor Human Epidermal growth factor Receptor-type 2 positive, pure or hybrid, stage III)

排除标准

  • Vitamina d supplementation women with breast carcinoma in situ, previous history of other cancers, chronic kidney disease (creatinine upper 1.4 milligrams/deciliter), liver disease, alcohol or drug addiction will be excluded

研究者

发起方
niversidade Estadual Paulista - Unesp

相似试验